ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)

Japan · Delayed Price · Currency is JPY

2,244.00

+11.00 (0.49%)

Jul 14, 2026, 3:30 PM JST

-4.79% (1Y)

Market Cap	63.72B -4.9%
Revenue (ttm)	71.13B +10.9%
Net Income	5.42B +6.3%
EPS	191.10 +6.2%
Shares Out	28.40M
PE Ratio	11.74
Forward PE	13.65
Dividend	65.00 (2.91%)
Ex-Dividend Date	Mar 30, 2026

Volume	44,400
Open	2,254.00
Previous Close	2,233.00
Day's Range	2,230.00 - 2,273.00
52-Week Range	1,920.00 - 3,045.00
Beta	0.45
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 4, 2026

About TYO:4886

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also i... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1920

Employees 1,611

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4886

Full Company Profile

Financial Performance

In fiscal year 2026, TYO:4886's revenue was 71.13 billion, an increase of 10.90% compared to the previous year's 64.14 billion. Earnings were 5.42 billion, an increase of 6.33%.

Financial Statements